Results for tag: "Vandetanib"

Vandetanib is a drug used to treat certain types of thyroid cancer. It is a tyrosine kinase inhibitor, meaning it works by blocking the action of certain proteins that can cause cancer cells to grow and divide. Vandetanib is used to treat medullary thyroid cancer, a rare form of thyroid cancer that is more difficult to treat than other types. It is also used to treat advanced thyroid cancer that has spread to other parts of the body. Vandetanib is usually taken in combination with other drugs, such as radioactive iodine or chemotherapy. Vandetanib is available in both generic and brand-name forms. It is manufactured by several pharmaceutical companies, including AstraZeneca, GlaxoSmithKline, and Novartis. It is also available in combination with other drugs, such as radioactive iodine or chemotherapy. The market for Vandetanib is growing as more people are diagnosed with thyroid cancer. It is an important treatment option for those with advanced or difficult-to-treat thyroid cancer. Companies in the Vandetanib market include AstraZeneca, GlaxoSmithKline, Novartis, and other pharmaceutical companies. Show Less Read more